
- Applied Clinical Trials-04-01-2014
- Volume 23
- Issue 4
Delivery Strength from Midsize CROs
ISR
There is no denying that large contract research organizations (CROs) are increasing their share of the outsourced drug development market. Preferred provider lists are dominated by the large CROs and it seems every week brings a new announcement of a "strategic partnership" between a large pharmaceutical company and a large CRO. However, one thing ISR has learned over the years of measuring delivery quality and loyalty is that being viewed as the "leader" does not guarantee a CRO a spot among the most favored. Similarly, record sales generation does not always translate to ensuring the most loyal customer base.
In ISR's new CRO Quality Benchmarking – Phase II/III Service Providers report, the data indicate the pendulum is swinging back toward the small or midsize CROs, at least from a delivery perspective (see chart below).
ISR is not suggesting that the large CROs possess disloyal, disgruntled customers Some are, in fact, quite strong. But four of the top five loyalty ratings in this year's Benchmarking study belong to small or midsize CROs.
The great news for study sponsors is they have choices. Whether the choice is driven by delivery quality, capabilities, relationship management, or something else, sponsors have viable options.
— Industry Standard Research
Articles in this issue
over 11 years ago
Oncology Trial Comparator Drug Reimbursement: A Canadian Perspectiveover 11 years ago
Business and People April 2014over 11 years ago
Europe Puts Renewed Emphasis on Patient Communicationover 11 years ago
Making a Difference in Cancer Trials Accrualover 11 years ago
Analyzing 2013 Oncology Trends to Predict 2014 Directionsover 11 years ago
Singular Approaches to Combination Trialsover 11 years ago
Pressure Grows for More Inclusive Clinical Trialsover 11 years ago
Coming to Terms with Interrupted Drug Development Programsover 11 years ago
The New Road of Cardio-Oncology in Clinical Developmentover 11 years ago
ACT coverNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.